RODMAN & RENSHAW INVESTMENT CONFERENCE, NEW YORK

Meet the future of antibody-based immuno-oncology drugs.

CEO Per Norlén is presenting the company at the 20th Annual Rodman & Renshaw Global Investment Conference in New York on September 6, at 3.25 pm EDT (9:25 pm CEST).

The presentation can be followed live and afterwards at http://wsw.com/webcast/rrshq28/atorx/.

Alligator Bioscience Capital Markets Day in Stockholm on May 29, 2018

Meet the future of antibody-based immuno-oncology drugs.

Listen to the presentations here.

Frontier

A magazine about Alligator Bioscience and immuno-oncology